Echographic detection of diethylnitrosamine-induced liver tumors in rats and the effect of the intratumoral injection of an inhibitor of c-Jun N-terminal kinase

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 5, 2009, Pages 866-871

  Hanajiri, Kazuyuki ^b   Mitsui, Hiroshi ^a,b   Maruyama, Toshiyuki ^b   Hashimoto, Naoaki ^c   Sata, Masataka ^a   Omata, Masao ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b Department of Gastroenterology ^*  (Japan)

^c TOKYO TEISHIN HOSPITAL   (Japan)

Author keywords

C Jun N terminal kinase; Carcinogenesis; Diethylnitrosamine; Hepatocellular carcinoma; Rat

Indexed keywords

ANTHRA[1,9 CD]PYRAZOL 6(2H) ONE; CELL NUCLEUS ANTIGEN; CYCLINE; DIETHYLNITROSAMINE; STRESS ACTIVATED PROTEIN KINASE INHIBITOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CARCINOGENESIS; CHEMICALLY INDUCED DISORDER; CONTROLLED STUDY; ECHOGRAPHY; GROWTH RATE; LIVER TUMOR; MALE; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; ANTHRACENES; ANTINEOPLASTIC AGENTS; CELL LINE, TUMOR; CELL PROLIFERATION; DIETHYLNITROSAMINE; DOSE-RESPONSE RELATIONSHIP, DRUG; INJECTIONS, INTRALESIONAL; JNK MITOGEN-ACTIVATED PROTEIN KINASES; LIVER; LIVER NEOPLASMS; MALE; PROLIFERATING CELL NUCLEAR ANTIGEN; PROTEIN KINASE INHIBITORS; RATS; RATS, WISTAR; TIME FACTORS;

EID: 65949085607     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2008.05722.x     Document Type: Article

References (29)

1. Wands JR. Prevention of hepatocellular carcinoma. N. Engl. J. Med. 2004 351 : 1567 70. (Pubitemid 39315325)
2. Branda M, Wands JR. Signal transduction cascades and hepatitis B and C related hepatocellular carcinoma. Hepatology 2006 43 : 891 902. (Pubitemid 43724611)
3. Gerolami R, Cardoso J, Lewin M et al. Evaluation of HSV-tk gene therapy in a rat model of chemically induced hepatocellular carcinoma by intratumoral and intrahepatic artery routes. Cancer Res. 2000 60 : 993 1001. (Pubitemid 30129536)
4. Nakaji M, Yano Y, Ninomiya T et al. IFN-alpha prevents the growth of pre-neoplastic lesions and inhibits the development of hepatocellular carcinoma in the rat. Carcinogenesis 2004 25 : 389 97. (Pubitemid 38344406)
5. Maeda S, Kamata H, Luo JL, Leffert H, Karin M. IKKβ couples hepatocyte death to cytokine-driven compensatory proliferation that promotes chemical hepatocarcinogenesis. Cell 2005 121 : 977 90. (Pubitemid 40884391)
6. Mai W, Barraud L, Lefrancois L et al. Ultrasound detection of spontaneous hepato-cellular carcinomas in X/myc bitransgenic mice. Liver Int. 2004 24 : 651 7. (Pubitemid 40028620)
7. Schmitz V, Tirado-Ledo L, Tiemann K et al. Establishment of an orthotopic tumour model for hepatocellular carcinoma and non-invasive in vivo tumour imaging by high resolution ultrasound in mice. J. Hepatol. 2004 40 : 787 91. (Pubitemid 38507359)
8. Graham KC, Wirtzfeld LA, MacKenzie LT et al. Three-dimensional high-frequency ultrasound imaging for longitudinal evaluation of liver metastases in preclinical models. Cancer Res. 2005 65 : 5231 7. (Pubitemid 40827333)
9. Johnson GL, Lapadat R. Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases. Science 2002 298 : 1911 2. (Pubitemid 35425238)
10. Bogoyevitch MA, Boehm I, Oakley A, Ketterman AJ, Barr RK. Targeting the JNK MAPK cascade for inhibition: basic science and therapeutic potential. Biochim. Biophys. Acta 2004 1697 : 89 101. (Pubitemid 38326764)
11. Eferl R, Ricci R, Kenner L et al. Liver tumor development: c-Jun antagonizes the proapoptotic activity of p53. Cell 2003 112 : 181 92. (Pubitemid 36144108)
12. Hilberg F, Aguzzi A, Howells N, Wagner EF. c-Jun is essential for normal mouse development and hepatogenesis. Nature 1993 365 : 179 81. (Pubitemid 23282066)
13. Shwabe RF, Bradham CA, Uehara T et al. c-Jun-N-terminal kinase drives cyclin D1 expression and proliferation during liver regeneration. Hepatology 2003 37 : 824 32. (Pubitemid 36397393)
14. Hanajiri K, Maruyama T, Kaneko Y et al. Microbubble-induced increase in ablation of liver tumors by high-intensity focused ultrasound. Hepatol. Res. 2006 36 : 308 14.
15. Satoh K, Hatayama I. Anomalous elevation of glutathione S-transferase P-form (GST-P) in the elementary process of epigenetic initiation of chemical hepatocarcinogenesis in rats. Carcinogenesis 2002 23 : 1193 98.
16. Kogure K, Ishizaki M, Nemoto M, Kuwano H, Makuuchi M. A comparative study of the anatomy of rat and human livers. J. Hepatobiliary Pancreat. Surg. 1999 6 : 171 5.
17. Sakurai T, Maeda S, Chang L, Karin M. Loss of hepatic NF-B activity enhances chemical hepatocarcinogenesis through sustained c-Jun N-terminal kinase 1 activation. Proc. Natl. Acad. Sci. USA 2006 103 : 10544 51. (Pubitemid 44078014)
18. Bennett BL, Sasaki DT, Murray BW et al. SP600125, an anthrapyrazolone inhibitor of Jun N-terminal kinase. Proc. Natl. Acad. Sci. USA 2001 98 : 13681 6.
19. Schiffer E, Housset C, Cacheux W et al. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis. Hepatology 2005 41 : 307 14. (Pubitemid 40165374)
20. Yoshiji H, Kuriyama S, Yoshii J et al. Halting the interaction between vascular endothelial growth factor and its receptors attenuates liver carcinogenesis in mice. Hepatology 2004 39 : 1517 24. (Pubitemid 38702652)
21. Chattopadhyay MB, C B MK, Kanna PS, Ray RS, Roy S, Chatterjee M. Combined supplementation of vanadium and beta-carotene suppresses placental glutathione S-transferase-positive foci and enhances antioxidant functions during the inhibition of diethylnitrosamine-induced rat liver carcinogenesis. J. Gastroenterol. Hepatol. 2004 19 : 683 93. (Pubitemid 38858203)
22. Kagawa M, Sano T, Ishibashi N et al. An acyclic retinoid, NIK-333, inhibits N-diethylnitrosamine-induced rat hepatocarcinogenesis through suppression of TGF-alpha expression and cell proliferation. Carcinogenesis 2004 25 : 979 85.
23. Umemura T, Kai S, Hasegawa R et al. Prevention of dual promoting effects of pentachlorophenol, an environmental pollutant, on diethylnitrosamine-induced hepato- and cholangiocarcinogenesis in mice by green tea infusion. Carcinogenesis 2003 24 : 1105 9. (Pubitemid 36827263)
24. Yang R, Kopecky KK, Rescorla FJ, Galliani CA, Grosfeld JL. Changes of hepatoma echo patterns with tumor growth. A study of the microanatomic basis in a rat model. Invest. Radiol. 1993 28 : 507 12. (Pubitemid 24076787)
25. Kuriyama S, Tsuijimoto T, Nakatani Y et al. Sonographic detection of liver tumor development induced by oral administration of thioacetamide in rat. In Vivo 1999 13 : 129 34. (Pubitemid 29229733)
26. Oh JY, Jeong JS, Kim YJ et al. Ultrasonographic evidence of phenotypic instability during hepatocarcinogenesis in N-nitrosomorpholine-treated rats. Exp. Mol. Pathol. 2002 73 : 67 73.
27. Cheng J, Imanishi H, Liu W et al. Involvement of cell cycle regulator proteins and MAP kinase signaling pathway in growth inhibition and cell cycle arrest by a selective cyclooxygenase 2 inhibitor, etodolac, in human hepatocellular carcinoma cell lines. Cancer Sci. 2004 85 : 666 73. (Pubitemid 39255815)
28. Thevananther S, Sun H, Li D et al. Extracellular ATP activates c-Jun N-terminal kinase signaling and cell cycle progression in hepatocytes. Hepatology 2004 39 : 393 402. (Pubitemid 38222180)
29. Kuntzen C, Sonuc N, De Toni EN et al. Inhibition of c-Jun-N-terminal- kinase sensitizes tumor cells to CD95-induced apoptosis and induces G2/M cell cycle arrest. Cancer Res. 2005 65 : 6780 8. (Pubitemid 41060716)